Alopecia Areata: WCH23 Seminar-in-Depth
At the completion of this activity, participants should be better able to:
Discuss the data on JAK inhibitors for the management of alopecia areata
Identify strategies to incorporate novel therapies for alopecia areata into clinical practice
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.